semaglutide/tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Semaglutide, tirzepatide recommended as first-line

Lower treatment rates were particularly evident among women, older individuals, patients with non-coronary atherosclerotic cardiovascular disease, and those lacking follow-up in specialized cardiology or diabetes clinics

Reference: R Kamika, M Kimberly, V Chintan et al

They can track your progress, adjust your nutrition and activity plan when needed, and provide strategies for challenges that come up

47,48 By emulating the biological activity of natural GLP-1, GLP-1RAs effectively fulfill the role of GLP-1, effectively lowering blood glucose levels without increasing the risk of hypoglycemia and demonstrating favorable safety profiles

Plan tier and formulary differences Even within the same employer, different plan options may have different formularies